Nasdaq

Lexicon Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides R&D Updates

THE WOODLANDS, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended September 30, 2025, and provided an ...
Nasdaq

Lexicon Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Lexicon Pharmaceuticals, Inc. announced that it will release its financial results for the fourth quarter and full year 2024 on March 6, 2025, after market close. Following the release, the company's ...
Seeking Alpha

Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

THE WOODLANDS, Texas, March 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) (Nasdaq: LXRX), today reported financial results for the three months and year ended December 31, 2024, ...
manilatimes

Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates

THE WOODLANDS, Texas, May 07, 2026 (GLOBE NEWSWIRE)-- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended March 31, 2026, and provided an update ...
Seeking Alpha

Lexicon Appoints Scott Coiante as Chief Financial Officer

THE WOODLANDS, Texas, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) today announced the appointment of Scott Coiante as senior vice president and chief financial officer, ...